BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9672772)

  • 1. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
    Cheson BD; Vena DA; Barrett J; Freidlin B
    J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S; Kantarjian H; Keating MJ
    Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
    Saven A; Piro LD
    Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
    Cabanillas F
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):13-5. PubMed ID: 10887639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
    Pott-Hoeck C; Hiddemann W
    Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
    Nabhan C; Gartenhaus RB; Tallman MS
    Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine nucleoside analogues in the treatment of myleoid leukemias.
    Robak T
    Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
    Tondini C; Balzarotti M; Rampinelli I; Valagussa P; Luoni M; De Paoli A; Santoro A; Bonadonna G
    Ann Oncol; 2000 Feb; 11(2):231-3. PubMed ID: 10761763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antimetabolites in the treatment of human malignancies.
    Cheson BD
    Semin Oncol; 1992 Dec; 19(6):695-706. PubMed ID: 1361080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine analogs in lymphoproliferative disorders.
    Cheson BD
    Leuk Lymphoma; 1993; 11 Suppl 2():153-9. PubMed ID: 7907252
    [No Abstract]   [Full Text] [Related]  

  • 15. Cladribine in indolent non-Hodgkin's lymphoma.
    Sigal DS; Saven A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):535-45. PubMed ID: 18402520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies.
    Johnson SA; Thomas W
    Hematol Oncol; 2000 Dec; 18(4):141-153. PubMed ID: 11135355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin in chronic lymphocytic leukemia.
    Sauter C; Lamanna N; Weiss MA
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of purine analogs: a review.
    Cheson BD; Vena DA; Foss FM; Sorensen JM
    J Clin Oncol; 1994 Oct; 12(10):2216-28. PubMed ID: 7931492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.